The International Genetics & Translational Research in Transplantation Network (iGeneTRAIN) comprises 22 studies to date. It includes 16,170 transplant recipients and 11,394 donors. We are always looking to expand further, and if you are interested in joining our network, or have any questions feel free to send us an email. Founding member sites are linked below.

The University of Pennsylvania Transplant Institute
Penn’s role in the network is managed by Avi Shaked and Brendan Keating, who are also part of the iGeneTRAiN leadership.

Wellcome Trust Case Control Consortium 3 (WTCCC3)
Interactions between Donor and Recipient DNA that determine Early and Late Renal Transplant Dysfunction.
PI: Graham Lord

Long-term Deterioration of Kidney Allograft Function (DeKAF) (NIH)
PI: Arthur Matas, Genetic epidemiology
Project Leader: Ajay Israni
Pharmacogenomics Project Leader: Pamala Jacobson

Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL) (NIH)
Co-PI: Kim Olthoff
Co-PIs: Abraham Shaked

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant (A-WISH) (NIH)
Protocol Chair: Avi Shaked

Clinical Trials in Organ Transplantation (CTOT-03) project (NIH)
PI: Avi Shaked

UPenn Liver donor recipient biobank
PI: Avi Shaked

Children’s Hospital of Philadelphia (heart, liver, lung and kidney)
PI: Brendan Keating

Madrid Heart Transplant Biobank
PI: Pablo Garcia

The Netherland National Heart Transplant Biobank
PI: Folkert Asselbergs